• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume9, Issue4

Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries

    Dr. Kalluri Saipriyanka, Dr. Satyanarayana Kuruba Pujari, Dr. Paresh Nagwekar, Dr. Shree Harsha M

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 4, Pages 3788-3793

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Bupivacaine is three to four times more potent than lignocaine4 and has a longer duration of action. Bupivacaine is an amide group of drug that is most frequently used for spinal anaesthesia. Both hyperbaric and isobaric forms are available. Hyperbaric solutions produce a more predictable extension of sensory block, short duration of block and faster recovery than isobaric solutions. The study was undertaken after obtaining ethical committee clearance as well as informed consent from all the patients. One hundred and twenty six patients in the age group between 20 years and 60 years of either sex belonging to ASA I and II posted for elective lower abdominal surgeries were grouped randomly into two groups (n=63). The mean time taken for attaining the maximum sensory blockade is 8.62±2.08 minutes in Group 1 and in Group 2 it is 8.71±2.59 minutes. Statistically there is no significance between the groups (p>0.05). The mean time taken to achieve maximum motor blockade in Group 1 is 7.03±2.24 minutes and in Group 2 it is 8.56±2.49 minutes, which is statistically significant between the groups (p<0.001).
 
Keywords:
  • PDF (172 K)
  • XML
(2022). Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries. European Journal of Molecular & Clinical Medicine, 9(4), 3788-3793.
Dr. Kalluri Saipriyanka, Dr. Satyanarayana Kuruba Pujari, Dr. Paresh Nagwekar, Dr. Shree Harsha M. "Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries". European Journal of Molecular & Clinical Medicine, 9, 4, 2022, 3788-3793.
(2022). 'Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries', European Journal of Molecular & Clinical Medicine, 9(4), pp. 3788-3793.
Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries. European Journal of Molecular & Clinical Medicine, 2022; 9(4): 3788-3793.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 25
  • PDF Download: 51
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus